MedPath

Improving Evidence-Based Care for Cancer Patients

Active, not recruiting
Conditions
Head and Neck Cancer
Lung Cancer
Gynecologic Cancer
Gastrointestinal Cancer
Prostate Cancer
Breast Cancer
Interventions
Other: Survey
Other: Saliva sample
Other: Smoking Status questions
Registration Number
NCT03207594
Lead Sponsor
Medical University of South Carolina
Brief Summary

The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
128
Inclusion Criteria
  • Diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancer
  • 21 years of age or older at time of study registration
  • Must have been referred to MUSC radiation oncology for treatment with curative radiation therapy
  • Must report current smoking defined as self-reporting smoking within the past 30 days using a structured intake questionnaire.
Read More
Exclusion Criteria
  • Patients with primary central nervous system malignancies will be excluded.
  • Patients that have other cancer disease types will be excluded due to either significant differences in standard radiation therapy approaches or rarity of disease required radiation.
  • Patients who are currently participating in the Medical University of South Carolina Hollings Cancer Center smoking cessation program
  • Patients who are unable to provide informed consent
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Arm 1Saliva sampleCurrent smokers with cancer who are planning to get radiation therapy at MUSC.
Arm 1SurveyCurrent smokers with cancer who are planning to get radiation therapy at MUSC.
Arm 1Smoking Status questionsCurrent smokers with cancer who are planning to get radiation therapy at MUSC.
Primary Outcome Measures
NameTimeMethod
Number of patients with biochemically confirmed smoking cessation4 weeks after enrollment

Biochemical confirmation will be determined by saliva samples

Number of patient who self-report smoking cessation4 weeks after enrollment

Self-reported smoking cessation will be documented via smoking assessment questionnaire

Secondary Outcome Measures
NameTimeMethod
Average weekly smoke exposureup to 62 weeks

reported cigarettes per day multiplied by the number of days smoked during radiation therapy (RT), summed over a period of time and normalized to yield an average weekly smoke exposure during RT.

Number of patients who participate in smoking cessationup to 12 months after completion of RT.

Completing one in-person visit where an individualized smoking cessation treatment plan is developed and implemented.

Compliance with smoking cessationup to 12 weeks after completion of RT

Two binary measure of compliance:

1. - completing at least three in person visits within 6 weeks of starting an individualized cessation treatment plan

2. - completing at least one in-person visit and at least two phone-based communications

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath